Evidence map›Paper›PMID 34861740›Full record

ArticleAorta (Stamford, Conn.)2021

Bicuspid Aortic Valve: Genetic and Clinical Insights.

Idit Tessler, Juliette Albuisson, Guillaume Goudot, Shai Carmi, Shoshana Shpitzen, Emmanuel Messas, Dan Gilon, Ronen Durst

Open access · hybridAbstract read
In one paragraph

Article in Aorta (Stamford, Conn.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Valvulopathies and Genetics: Where are We?Reviews in cardiovascular medicine · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Idit TesslerDepartment of Cardiology, Hadassah Medical Center, Jerusalem, Israel.ORCID 0000-0002-3297-7022
Juliette AlbuissonOncogenetics laboratory, Centre George François Leclerc, Dijon, France.ORCID 0000-0002-8947-6499
Guillaume GoudotCardiovascular Department, Georges Pompidou European Hospital, Paris, France.
Shai CarmiFaculty of Medicine, The Hebrew University, Jerusalem, Israel.ORCID 0000-0002-0188-2610
Shoshana ShpitzenDepartment of Cardiology, Hadassah Medical Center, Jerusalem, Israel.
Emmanuel MessasCardiovascular Department, Georges Pompidou European Hospital, Paris, France.
Dan GilonDepartment of Cardiology, Hadassah Medical Center, Jerusalem, Israel.
Ronen DurstDepartment of Cardiology, Hadassah Medical Center, Jerusalem, Israel.
Hebrew University of Jerusalem · ILHôpital Européen Georges-Pompidou · FRCentre Georges François Leclerc · FRHadassah Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bicuspid aortic valve (BAV) is the most common valvular congenital heart disease, with a prevalence of 0.5 to 2% in the general population. Patients with BAV are at risk for developing cardiovascular complications, some of which are life-threatening. BAV has a wide spectrum of clinical presentations, ranging from silent malformation to severe and even fatal cardiac events. Despite the significant burden on both the patients and the health systems, data are limited regarding pathophysiology, risk factors, and genetics. Family studies indicate that BAV is highly heritable, with autosomal dominant inheritance, incomplete penetrance, variable expressivity, and male predominance. Owing to its complex genetic model, including high genetic heterogenicity, only a few genes were identified in association with BAV, while the majority of BAV genetics remains obscure. Here, we review the different forms of BAV and the current data regarding its genetics. Given the clear heritably of BAV with the potential high impact on clinical outcome, the clinical value and cost effectiveness of cascade screening are discussed.

Identifiers

PMID34861740
PMCPMC8642070
OpenAlexW3215110132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.